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Abstract: The control of human Campylobacteriosis is a priority in public health agendas 
all over the world. Poultry is considered a significant risk factor for human infections with 
Campylobacter and risk assessment models indicate that the successful implementation of 
Campylobacter control strategies in poultry will translate on a reduction of human 
Campylobacteriosis cases. Efficient control strategies implemented during primary 
production will reduce the risk of Campylobacter introduction in chicken houses and/or 
decrease Campylobacter concentration in infected chickens and their products. 
Consequently, poultry producers need to make difficult decisions under conditions of 
uncertainty regarding the implementation of Campylobacter control strategies. This 
manuscript presents the development of probabilistic graphical models to support decision 
making in order to control Campylobacter in poultry. The decision support systems are 
constructed as probabilistic graphical models (PGMs) which integrate knowledge and use 
Bayesian methods to deal with uncertainty. This paper presents a specific model designed 
to integrate epidemiological knowledge from the United Kingdom (UK model) in order to 
assist poultry managers in specific decisions related to vaccination of commercial broilers 
for the control of Campylobacter. Epidemiological considerations and other crucial aspects 
including challenges associated with the quantitative part of the models are discussed in 
this manuscript. The outcome of the PGMs will depend on the qualitative and quantitative 
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data included in the models. Results from the UK model and sensitivity analyses indicated 
that the financial variables (cost/reward functions) and the effectiveness of the control 
strategies considered in the UK model were driving the results. In fact, there were no or 
only small financial gains when using a hypothetical vaccine B (able to decrease 
Campylobacter numbers from two to six logs in 20% of the chickens with a cost of  
0.025 £/chicken) and reward system 1 (based on similar gross profits in relation to 
Campylobacter levels) under the specific assumptions considered in the UK model. In 
contrast, significant reductions in expected Campylobacter numbers and substantial 
associated expected financial gains were obtained from this model when considering the 
reward system 2 (based on quite different gross profits in relation to Campylobacter levels) 
and the use of a hypothetical cost-effective vaccine C (able to reduce the level of 
Campylobacter from two to six logs in 90% of the chickens with a cost of 0.03 £/chicken). 
The flexibility of probabilistic graphical models allows for the inclusion of more than one 
Campylobacter vaccination strategy and more than one reward system and consequently, 
diverse potential solutions for the control of Campylobacter may be considered.  
Cost-effective Campylobacter control strategies that can significantly reduce the 
probability of Campylobacter introduction into a flock and/or the numbers of 
Campylobacter in already infected chickens, and translate to an attractive cost-reward 
balance will be preferred by poultry producers. 
Keywords: Campylobacter control; epidemiology; poultry; public health; probabilistic 
graphical models; decision support systems 
 
1. Introduction 
Human infections with Campylobacter are considered an important public health problem all over 
the world and poultry has been identified as one of the most significant sources for human 
Campylobacteriosis [1–10]. Campylobacter can break through biosecurity barriers and enter poultry 
houses, colonizing the chicken intestine and quickly multiplying in the intestinal mucosa. However,
 
Campylobacter does not induce health or welfare problems in chickens [11]. After introduction, 
Campylobacter spreads fast within broiler flocks and almost all birds in the same house will be 
infected within one week [12]. Broilers might carry high numbers of Campylobacter in some cases 
exceeding 10
7
 colony forming units per gram (CFU/g) of caecal content [13] and sometimes up to  
10
10
 CFU/g of faeces
 
[14–16]. Campylobacter present in the intestinal tract of chickens going for 
slaughter might contaminate the slaughtering and food processing environment and the food products 
representing a public health risk for the consumers. Campylobacter seems to be highly infectious  
and humans may develop clinical disease with the ingestion of a Campylobacter dose as low as  
500 CFU [17,18]. Furthermore, humans can be infected from poultry by pathways other than poultry 
products and therefore increased public health benefits can be associated with the implementation of 
effective controls against Campylobacter in primary poultry production.
 
Vaccination of chickens 
against Campylobacter has been proposed as a promising Campylobacter control measure [19].  
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A previous risk assessment study has shown that a reduction of two logs on the numbers of 
Campylobacter in chickens can translate in a reduction of human cases by 30 times [20]. 
Consequently, decreasing the numbers of Campylobacter in chickens at the farm level seems crucial to 
prevent Campylobacter contamination of chicken products, which in turn will reduce the risk of human 
infections with Campylobacter. In the last few years, research studies have focused on the reduction of 
the probability of Campylobacter introduction in broiler flocks [3,21–24] but recently some studies 
have focused on the development of vaccination and other control strategies with the aim to reduce the 
concentration of Campylobacter in the intestines of already infected chickens [25–29]. 
Poultry producers need to make important decisions and sometimes expensive investments to 
control Campylobacter.
 
Incentives to differentiate the payment to poultry producers are implemented 
in some countries in order to improve the safety of poultry products regarding Campylobacter. For 
instance, in Denmark, when the microbiological test identifies a flock as Campylobacter negative a 
few days before slaughter, the producer gets an extra payment (around 2%) while in Norway and 
Sweden the payment is reduced by about 4% for flocks that test positive for Campylobacter [30].  
In this way, poultry producers need to make decisions under conditions of uncertainty mainly related  
to the possibility of the flock being infected with Campylobacter. Furthermore, there is always 
uncertainty around existing knowledge and the generalization of results from specific studies further 
increase the uncertainty surrounding the knowledge decisions are based on. Mathematical models can 
be used to simulate the effectiveness and economic impact of diverse control measures. The decision 
support systems presented in this manuscript are constructed as probabilistic graphical models (PGMs) 
which integrate knowledge in one representation and use a Bayesian approach to handle uncertainty. 
Due to the inclusion of uncertain variables in the models (with diverse “states” or alternatives) and the 
use of probability distributions, using a Bayesian inference seems logic when making decisions under 
conditions of uncertainty and in situations that require statistical inference [31]. The integration of 
prior evidence (prior probabilities) can be used to infer the probabilities of other variables (or states) 
that are not known (posterior probabilities) using a Bayesian approach. 
This manuscript describes the development of decision support models for poultry producers, 
focusing on the integration of qualitative and quantitative epidemiological data related to the effect of 
different management factors, in order to select optimal decisions regarding the cost-efficient controls 
that could be implemented to reduce Campylobacter concentration in chickens at farm level.
 
The 
development is exemplified by a model designed using data from the United Kingdom (UK) to assist 
decision-making related to the control of Campylobacter in chicken farms using vaccination strategies. 
Human Campylobacteriosis represents an important problem in the UK causing significant morbidity 
and socio-economic costs [32,33]. The number of reported human Campylobacteriosis cases in 2009 
was 57,772 in England and Wales, however, it has been estimated that the burden of human infection 
in 2009 could be closer to 400,000 [34]. An overall Campylobacter spp. prevalence of 79.2% in UK 
broilers going for slaughter was obtained in a stratified randomized survey conducted during  
2007–2009, including data from the EU baseline survey of 2008 [35]. 
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2. Materials and Methods 
2.1. Probabilistic Graphical Models (PGMs) 
Poultry producers need to make important decisions related to the implementation of interventions 
against Campylobacter in poultry flocks before they know for sure if the flock will be challenged or 
infected with Campylobacter. Probabilistic graphical models (PGMs) may assist poultry producers in 
these crucial decisions made under conditions of uncertainty. The probabilistic graphical models 
presented in this manuscript have been designed using the HUGIN tool which is a commercial  
off-the-shelf software package created for the construction and deployment of probabilistic graphical 
models. A very simple example of a PGM with just one input variable (that could be however the 
result of the interaction of many variables) is presented in Figure 1. 
In Figure 1, the probabilistic dependence relationships between a set of variables are illustrated 
using a probabilistic graphical model (formed by a set of variables) which has two components; a 
qualitative and a quantitative part. The qualitative part is represented by a directed acyclic graph 
(DAG) which includes diverse “nodes” such as variables, decision nodes and utility functions as well 
as arcs representing relationships between them. A decision node (a rectangle in Figure 1) defines 
decision alternatives at a specific point in time, a chance node (an oval) represents a random variable 
and a utility node (a diamond in Figure 1) represents a reward or cost function. Arcs directed into a 
decision node define the information that is known by the decision maker at the time that the decision 
needs to be done. Each node includes a set of states or alternatives and the arcs represent the 
relationships between variables. The strength of the relationships between the entities included in the 
models can be defined using conditional probability distributions [36]. Variables, decision nodes and 
utility functions need to be carefully selected in order to obtain reliable outcomes. 
Figure 1. A simple probabilistic graphical model (PGM) to assist in a decision related to 
vaccination of poultry against Campylobacter. 
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Crucial challenges that might be encountered when developing the quantitative part of the models 
may be related to the following: 
(1) A selected random variable such as “biosecurity” could be influenced by many other factors or 
variables and for that reason it may be difficult to select one defined probability distribution to 
represent the group of factors. Furthermore, some of these factors may well be protective instead of 
risk factors based on particular epidemiological studies. In fact, results related to the same factor can 
be contradictory in different studies (e.g., pest control has been found to be a risk factor instead of a 
protective factor [5]). The presence of potential confounders could explain some epidemiological 
findings making the analysis and the models more complex. 
(2) Epidemiological studies are conducted in different areas of the world, diverse conditions, 
farming systems, sample sizes, sampling protocols, etc. Consequently, it seems challenging to design a 
general PGM that could be applied in all circumstances to support decision-making for Campylobacter 
vaccination of poultry. In fact, the quantitative part of the model should be based on one “standardized 
measure of risk”; however, epidemiological studies use different measurements or parameters to 
represent the concept of “increased or decreased risk” due to the factor/s considered in every case. 
Even when the parameter used is the same (e.g., Odds Ratio) the quantitative values can be very 
different between epidemiological studies. The statistical combination of results from two or more 
studies can be referred to as meta-analysis and needs to be produced with care [37]. 
(3) Although many epidemiological studies use the Odds Ratio as a measurement of risk 
attributable to the factor considered, this mathematical expression cannot be used in the PGMs as such. 
It is necessary to transform the Odds Ratio value to a fixed probability value or a specific distribution 
of potential values to be included in the quantitative part of the Bayesian models. The selection and in 
some cases the combination of different odds ratios or probabilities for their use in PGMs need to be 
carefully performed. Moreover, the use of sensitivity analysis has been recommended [38]. 
After careful design of the qualitative and the quantitative part of the models, the outcome of the 
models will include potential decisions related to Campylobacter control strategies that can be 
considered and selected for implementation. The solution of an influence diagram is a strategy 
consisting of a policy for each decision, for example, the use of vaccination strategy A (Figure 1). The 
strategy is determined using the principle of maximizing expected utility based on selecting a decision 
that will offer the decision maker the greatest expected reward. In this example, vaccination strategy A 
is able to reduce the expected numbers of Campylobacter in infected chickens. The results from the 
model will include posterior probability distributions (under the identified strategy) related to expected 
Campylobacter numbers in the flock (in logs) before and after the implementation of the decision/s and 
the expected cost-reward balance associated with each decision/s (Table 1). 
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Table 1. Hypothetical results from a PGM with one decision related to the use of 
Vaccination strategy A against Campylobacter in broilers. 
No vaccination  
Posterior probabilities related to  
expected Campylobacter levels: 
Vaccination strategy A  
Posterior probabilities related to  
expected Campylobacter levels: 
0–2 logs (7%) 0–2 logs (52%) 
2–4 logs (20%) 2–4 logs (18%) 
4–6 logs (23%) 4–6 logs (12%) 
6–8 logs (24%) 6–8 logs (10%) 
8–10 logs (26%) 8–10 logs (8%) 
Expected cost-reward balance:  Expected cost-reward balance:  
+0.36 euros/chicken  +0.44 euros/chicken  
Expected cost-reward balance  
(gross profit) for an average flock with  
20,000 chickens: 7200 euros 
Expected cost-reward balance  
(gross profit) for an average flock with  
20,000 chickens: 8800 euros 
The model presented in Figure 1 is an influence diagram [39] constructed around the decision on 
vaccination against Campylobacter but other control strategies could be considered in the models. The 
flexibility of this methodology allows the user to consider different costs depending on the diverse 
strategies used to control Campylobacter. Similarly, several reward strategies can be accounted for in 
the models. In the presented model, the reward is based on the level of Campylobacter (logs) around 
slaughter time. 
In the model presented in Figure 1, the decision node is based on performing vaccination against 
Campylobacter in broilers at two weeks of age. Campylobacter is not usually detected in birds younger 
than two weeks [40,41]. It has been suggested that this “two weeks window” could be strategically 
used to introduce vaccination programs [42]. Therefore, the decision about vaccination in poultry 
needs to be made usually before Campylobacter is introduced into the flock, and there is uncertainty 
regarding the introduction of Campylobacter into the flock that needs to be taken into account in the 
decision-making process. For this reason, historical farm data related to previous Campylobacter status 
could be accounted for in the models. 
2.2. Case Study Model 
2.2.1. Current Knowledge Related to Poultry Management Factors 
Here, we present a decision model we have developed based on the results from an observational 
study on risk factors that could be associated with Campylobacter in broilers in the UK [35]. These 
authors conducted epidemiological studies based on 29 risk factors that could be potentially associated 
with Campylobacter status in broilers. The following risk factors were found significantly associated 
with Campylobacter positive flocks in the study: previous depopulation practices, higher recent flock 
mortality, increasing age at slaughter and slaughter in the summer months. We have included these risk 
factors for the presence of Campylobacter in UK broilers at slaughter in a probabilistic graphical 
model. The quantitative part (probabilities of events or states of the variables) of the PGM (Table 2) 
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was obtained by a mathematical transformation of odds ratio values presented in the study from the 
UK [35]. Additionally, probabilities related to Campylobacter introduction in the flock due to the 
presence of risk factors are conditional to a “baseline level” of Campylobacter (lowest level of 
Campylobacter in broilers close to slaughter time found in the literature). In these models, the 
“baseline Campylobacter flock prevalence” in the UK considered was 28.8% based on data from a 
study conducted by the Food Standards Agency [43]. 
The formula applied to calculate probabilities of the diverse states of risk factors (P(s)) based on the 
baseline Campylobacter flock prevalence (bp) and odds ratios (ORs) was: 
 exp(ln(b / (1 b )) ln(OR ))
( )
1 exp(ln(b / (1 )) ln(OR ))
p p s
p p s
P s
b
 

  
 
(1) 
Table 2. Significant risk factors, frequency of occurrence [35] and associated probability 
of Campylobacter introduction in UK broiler flocks. 
Risk factor and frequency 
of occurrence 
Odds Ratio (95% CI) 
Probability of a Campylobacter 
positive flock * due to the 
presence of specific risk factors 
Season   
Summer (26.32%) 14.27 (7.83–26.02) 0.85 
Autumn (25.38%) 1.70 (1.21–2.37) 0.41 
Spring or winter 
a
 (48.3%) 1  
Age of broilers   
≥46 days (19.59%) 13.43 (7.40–24.35) 0.85 
42–45 days (15.67%) 3.56 (2.39–5.29) 0.59 
40–41 days (18.57%) 3.18 (1.42–7.12) 0.57 
36–39 days (21.98%) 1.25 (0.86–1.81) 0.34 
<36 days 
a
 (24.19%) 1  
Flock recent mortality   
>1.49% (32.22%) 2.74 (1.18–6.40) 0.53 
1.00%–1.49% (29.35%) 1.57 (1.12–2.21) 0.39 
<1.00% 
a
 (38.43%) 1  
Previous partial depopulation   
Yes (64.94%) 5.21 (2.89–9.38) 0.68 
No 
a
 (35.06%) 1  
a
 Reference category (mathematical models); * Based on a baseline level of Campylobacter  
of 28.8% [44]. 
2.2.2. Cost-Reward Function 
Accurate cost-benefit analyses of potential control measures against a particular disease play a 
crucial role in the implementation of successful disease control programs. A cost-reward function was 
included in this model in order to assess the financial consequences of every decision that the farmer 
might consider to control Campylobacter in chickens. Financial data related to the UK poultry industry 
was obtained from a farm business survey from 2009/2010 [44]. There is no commercial 
Campylobacter vaccine at present and thus a commercial Campylobacter vaccine price is not 
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available. The cost of a hypothetical vaccine against Campylobacter in broilers could be considered to 
be between 2 and 6 Euro cents based on prices of other vaccines used in poultry production [45]. The 
vaccine effectiveness or vaccine impact was also hypothetical in these models. We decided to consider 
a hypothetical vaccine B against Campylobacter in broilers able to decrease Campylobacter numbers 
from two to six logs in 20% of the broilers and less than two logs in 80% of the chickens with a cost of  
0.025 £/chicken (UK). The reward system has been designed based on the reported average gross 
profit of 0.36 £/per chicken for UK farmers in 2010 [44]. Based on this hypothetical reward system 
(Table 3), farmers producing chickens with numbers of Campylobacter lower than four logs will get 
higher gross profits (+20% extra with respect to other Campylobacter levels) while farmers delivering 
chickens carrying high numbers of Campylobacter (more than six logs) will get lower gross profits  
(−20% between Campylobacter levels). It was assumed that an average broiler chicken from a positive 
flock in the UK will carry Campylobacter in a concentration of 4–6 log CFU/g or mL of sample (from 
the digestive tract). 
Table 3. Reward system 1 considered in the model. 
Campylobacter numbers (logs) 0–2 2–4 4–6 6–8 8–10 
Gross profit (£/chicken) 0.52 0.43 0.36 0.29 0.23 
2.2.3. Designing the PGM 
The model we present in this case study (Figure 2) was designed based on the following 
assumptions: 
(1) The contributions from different risk factors to the level of Campylobacter are independent. 
(2) It is considered that the detection level of Campylobacter is 2 logs CFU/g or mL of sample and 
the maximum colonization level is 10 logs CFU/g or mL of sample. This means that a Campylobacter 
level of 0–2 logs will give a negative result while a positive result includes Campylobacter numbers 
from 2 to 10 logs. In this model, we use intervals for bacterial concentration with two log widths  
(e.g., 0–2 logs, 2–4 logs, 4–6 logs, 6–8 logs and 8–10 logs). 
(3) Vaccination impact is based on log-reduction of the numbers of Campylobacter in chickens and 
therefore the numbers of Campylobacter in broilers going for slaughter will be lower after vaccination. 
(4) The “measured Campylobacter numbers at slaughter” will depend on the “true numbers” and the 
microbiological quantitative methods used. In these models, we assume a nearly-perfect quantitative 
method so the obtained Campylobacter numbers in the lab are closer to the numbers in reality. 
Epidemiological studies provide insight regarding the risk of Campylobacter introduction 
attributable to particular risk factors in specified conditions. However, there seems to be lack of data 
regarding the numbers of Campylobacter carried by broilers throughout the farming period in relation 
to particular risk factors. In the models presented here, the vaccination impact and the cost-reward 
functions are based on a log-scale because the objective is to develop a control strategy  
(e.g. vaccination strategy) able to reduce the numbers of Campylobacter in commercial broilers.  
In order to obtain reliable results from the model, data must be on the same scale. Data related to  
the effect of risk factors on the Campylobacter status of the flock are based on positive  
(2–10 logs)/negative (0–2 logs) results and they need to be translated to the expected distribution of 
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probabilities related to Campylobacter levels in the flock (Figure 3). The nodes “Campylobacter status 
before vaccination” and “Campylobacter status before vaccination (logs)” in this model specify the 
transformation from positive/negative to the diverse Campylobacter levels (in logs) scale (Figure 3). A 
flat distribution is used in this case to transform a general Campylobacter probability (e.g., 92.36%) 
into a distribution of equal probabilities for different levels of Campylobacter as illustrated in Figure 3. 
Figure 2. The model Commercial Broilers Vaccination (ComBVacUK) based on 
epidemiological and financial data from the UK. 
 
Figure 3. Illustration of the part of the model showing the Campylobacter status before 
vaccination in positive/negative format (0–2 logs is considered negative and 2–10 logs 
translates on a positive result) and in logs format (distribution of the different levels of 
Campylobacter in logs). 
 
The quantitative part of the models encodes the mathematical expressions and probability 
distributions associated with the different states of the chance variables and utility functions associated 
with the utility nodes as defined by the structure of the influence diagram. For example, the following 
mathematical expression: “max (prob_season, prob_previousdepop, prob_flock_recentmortality, 
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prob_age_at_slaughter)” is introduced in the variable “Campylobacter status before vaccination” to 
calculate the posterior conditional probabilities based on probability distributions from the parent 
variables (Figure 4). There are probability tables for each variable which include probabilities for 
every state of the variables. These tables will contain the prior probability distributions for variables 
without parents in the model and the conditional probability distributions for variables with parents. 
Figure 4 illustrates probability tables for the variables: prob_season, prob_previousdepop, 
prob_flock_recentmortality and prob_age_at_slaughter in the Commercial Broilers Vaccination 
(ComBVacUK) model. 
Figure 4. Probability tables for the variables: prob_season, prob_previousdepop, 
prob_flock_recentmortality and prob_age_at_slaughter. 
 
The prior probability distributions should integrate knowledge obtained from sources such as 
empirical observations, epidemiological data and experts in order to obtain reliable outcomes  
from the decision support models. Bayesian inference and probability theory set the basis for the 
quantitative outputs of the models. Decision support models can be updated with new evidence, 
knowledge or information. 
2.2.4. Sensitivity Analyses 
The aim of performing sensitivity analyses is to determine the sensitivity of the vaccination 
decision under different evidence scenarios with respect to single parameters of the models. In this 
particular case, two very different reward systems and a hypothetical vaccine C were included in the 
models. Reward system 2 was based on an extra payment for chickens testing Campylobacter negative 
of 2.5 times the normal price while reward system 3 was based on the existing reward systems in 
Denmark which is based on an extra payment of about 2% for flocks testing negative for 
Campylobacter and in Norway and Sweden where the payment is reduced by about 4% for flocks that 
are tested positive for Campylobacter (personal communication). A cost-efficient hypothetical vaccine 
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C able to reduce 2–6 logs the level of Campylobacter in 90% of the chickens was considered with a 
cost of 0.03 £/chicken. 
3. Results 
3.1. Results from the Model Commercial Broilers Vaccination UK Model (ComBVacUK) 
The results from the model can be visualized by selecting diverse combinations of “nodes states” 
and obtaining the output in terms of the expected distribution of probabilities related to Campylobacter 
levels and expected cost-reward balance in every case. A high number of potential combinations or 
scenarios can be considered and therefore it is up to the user to select the relevant combination of 
present factors. In Table 4, we have described three combinations in order to illustrate the potential 
outputs of the model. 
Table 4. Scenarios considered in the model; risk factors and their frequency of occurrence 
in every scenario. 
Best-case scenario  Worst-case scenario 
“Most likely” scenario (based 
on study data [35]) 
Spring or winter (100%) Summer (100%) Season 
  Summer (26.32%) 
  Autumn (25.38%) 
  Spring or winter 
a
 (48.3%) 
Age of broilers Age of broilers Age of broilers 
≤36 days (100%) ≥46 days (100%) ≥46 days (19.59%) 
  42–45 days (15.67%) 
  40–41 days (18.57%) 
  36–39 days (21.98%) 
  <36 days 
a
 (24.19%) 
Flock recent mortality
 
Flock recent mortality Flock recent mortality 
<1.00%
 
(100%) >1.49% (100%) >1.49% (32.22%) 
  1.00%–1.49% (29.35%) 
  <1.00% 
a
 (38.43%) 
Previous partial depopulation Previous partial depopulation Previous partial depopulation 
No (100%) Yes (100%) Yes (64.94%) 
  No 
a
 (35.06%) 
a
 Reference category (mathematical models). 
Results from the models (based on prior probabilities shown in Table 4) are included in Table 5 
where expected posterior probabilities and expected cost-reward financial balances are presented. 
Results from the model indicate that the financial results are relatively insensit ive to choices in this 
case. There are no or only small financial gains when using vaccine B and reward system 1 under the 
specific assumptions considered in the model. Actually, in the best-case scenario the farmer will not 
gain financially when using vaccine B although the posterior probabilities related to expected high 
numbers of Campylobacter in the flock will be reduced. On the contrary, in the worst-case scenario the 
best option will be to use vaccine B because it produces the maximum cost-reward balance  
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(0.34 £/chicken) and a reduction on the probabilities related to expected high numbers of 
Campylobacter in the flock. Similarly, results obtained when considering the “most-likely” scenario 
based on study data [35] indicate that the best option will be to use vaccine B. 
Table 5. Results based on the model Commercial Broilers Vaccination (ComBVacUK) 
using reward system1 (Table 3) and a hypothetical Campylobacter vaccine B. 
 Scenarios 
 Best-case scenario  Worst-case scenario 
“Most likely” scenario 
(based on study data 
from the UK [35]) 
Posterior 
probabilities related 
to expected 
Campylobacter levels 
when implementing 
no additional 
protective measure  
0–2 logs (25.70%) 0–2 logs (0.35%) 0–2 logs (7.27%) 
2–4 logs (18.58%) 2–4 logs (24.91%) 2–4 logs (23.18%) 
4–6 logs (18.58%) 4–6 logs (24.91%) 4–6 logs (23.18%) 
6–8 logs (18.58%) 6–8 logs (24.91%) 6–8 logs (23.18%) 
8–10 logs (18.58%) 8–10 logs (24.91%) 8–10 logs (23.18%) 
Cost-reward balance: 
0.38 £/chicken 
Cost-reward balance: 
0.33 £/chicken 
Cost-reward balance: 
0.34 £/chicken 
Flock with 50,000 
chickens = 19,000 £ 
Flock with 50,000 
chickens = 16,500 £ 
Flock with 50,000 
chickens = 17,000 £ 
Posterior 
probabilities related 
to expected 
Campylobacter levels 
after the 
implementation of a 
decision (Vaccine B) 
Vaccine B Vaccine B Vaccine B 
0–2 logs (35%) 0–2 logs (12.82%) 0–2 logs (18.87%) 
2–4 logs (18.59%) 2–4 logs (24.94%) 2–4 logs (23.21%) 
4–6 logs (17.67%) 4–6 logs (23.70%) 4–6 logs (22.05%) 
6–8 logs (15.81%) 6–8 logs (21.21%) 6–8 logs (19.74%) 
8–10 logs (12.93%) 8–10 logs (17.34%) 8–10 logs (16.14%) 
Expected cost-reward 
balance: 0.38 £/chicken 
Expected cost-reward 
balance: 0.34 £/chicken 
Expected cost-reward 
balance: 0.35 £/chicken 
Flock with 50,000 
chickens = 19,000 £ 
Flock with 50,000 
chickens = 17,000 £ 
Flock with 50,000 
chickens = 17,500 £ 
3.2. Results from the Sensitivity Analyses 
Sensitivity analyses performed indicated that the factors that influenced the results to a greater 
extent were the financial variables (cost/reward functions) and the effectiveness of the control strategy, 
e.g. vaccination impact. On the other hand, the results showed that the financial differences between 
diverse strategies were very small mainly due to the narrow differences between the levels of the 
reward system. The results indicated that when applying the reward system 2 (a system with higher 
differences between gross benefits obtained by farmers delivering chickens Campylobacter negative or 
with low Campylobacter numbers), the best solution in terms of maximum expected benefit would be 
using the vaccine C in all case-scenarios. Significant reductions in expected Campylobacter levels and 
substantial associated expected financial gains were obtained from this model when considering the 
reward system 2 and the use of vaccine C; for example, in the most-likely scenario, the expected 
benefit increased from 0.34 £/chicken to 0.69 £/chicken (translated to a flock with 50,000 chickens, 
from 17,000 £ to 34,500 £). However, when implementing reward system 3 (closer to real reward 
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systems currently employed in several countries) the best solution in financial terms will be “not 
vaccinating” even though the use of vaccine C could potentially reduce the expected posterior 
probabilities related to high numbers of Campylobacter in the flock significantly. In fact, the use of a 
hypothetical vaccine C in the most-likely scenario could reduce the probability of Campylobacter 
introduction into the flock from around 93% to approximately 46%. 
4. Discussion 
Poultry producers need to make important, complex decisions and related investments for the 
sustainability of their businesses. Increased consumer concerns related to food safety put pressure on 
food producers to implement food safety assurance systems. In particular, poultry producers should 
implement effective controls against Campylobacter in poultry to increase food safety and to reduce 
the burden of human Campylobacteriosis. 
Different PGMs can be developed to assist in decision-making regarding Campylobacter 
vaccination of poultry and/or other Campylobacter control strategies. The graphical nature and 
decomposition into variables and relationships of PGMs make it possible to create a common generic 
model to assess diverse strategies for the control of Campylobacter in poultry. Nevertheless, it seems 
challenging to design a general model (qualitative and quantitative) that could be applied to all 
situations, poultry farming conditions and geographical areas. Furthermore, the conditions, selection of 
factors or variables, different parts of the models, and quantitative data need to be clearly specified to 
add value and perspective to the decision support system designed in every case. Tailor-made properly 
developed PGMs will help poultry managers make important decisions in order to solve complex 
problems such as the control of Campylobacter. PGMs can be extended and/or modified to adapt to 
different real circumstances. For example, the time of slaughter might vary depending on the final 
product. In addition, the assumption about independence between factors gives flexibility to include 
supplementary factors or new knowledge in the model. 
Microbiological methods for the detection and quantification of Campylobacter can be used to 
assess the Campylobacter status of birds. However, it seems important to distinguish between the true 
numbers of Campylobacter in birds and the detected or measured numbers. There are several 
microbiological techniques available for the detection and enumeration of Campylobacter spp. from 
different sample matrices. However, some techniques are still under development and the detection 
limit of most methodologies seems to be 100 CFU/g or mL (depending on sample type and sample 
preparation). Therefore, a negative result might actually indicate very low numbers of Campylobacter 
(1–100 CFU/g or mL). Moreover, microbiological sampling and processing methods will not be 
perfect and in reality, the sampling procedures and microbiological techniques will affect the estimates 
of the true numbers of Campylobacter in chickens and in poultry flocks. In this model, we assumed a 
nearly-perfect quantitative method but other tests and/or other uncertainties related to microbiological 
sampling could be considered in the models. Similarly, diverse sources of contamination of broiler 
flocks could be included. Sources of Campylobacter contamination might be implicit in some risk 
factors (e.g., biosecurity). In this model, the presence of flies (a potential source of Campylobacter 
contamination) could be a confounder with the risk factor “season: summer”. Nevertheless, other 
potential Campylobacter sources could be considered, increasing the complexity of the models. 
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In the UK, human Campylobacteriosis represents an important public health problem [32,33]. 
Estimates of Campylobacter prevalence in UK poultry flocks can be found in the literature, e.g., 75% 
in the EU baseline survey carried out in 2008 [46] and 79.2% in the considered study from the UK [35] 
which are average prevalence values obtained from sampling a number of poultry flocks for human 
consumption. The introduction of Campylobacter in the food processing environment poses a risk for 
the contamination of food products; in fact, in the EU baseline survey carried out in 2008, 86% of the 
UK poultry carcasses tested were found positive for Campylobacter. It seems crucial to reduce the 
number of Campylobacter positive flocks and the numbers of Campylobacter in chickens and their 
products. The control of Campylobacter in poultry could translate to a decrease in the incidence of 
human Campylobacteriosis cases in the UK. 
The results from the model presented here indicated that the posterior probability of introduction of 
Campylobacter into the UK poultry flock in the most likely scenario before vaccination was 92.36% 
based on the assumptions and data specified in this manuscript. The posterior probability of 
Campylobacter introduction into the flock decreased significantly by the use of a hypothetical vaccine B 
(to approximately 81%) and even more when using a much more effective hypothetical vaccine C (to 
approximately 46%). The results indicated that the public health impact of the control strategies will 
depend on the effectiveness of the controls. However, the assessment of the effectiveness of diverse 
control strategies might prove challenging in some cases, e.g., the assessment of vaccine effectiveness [29]. 
In any case, decreasing the probability of Campylobacter introduction into poultry flocks is highly 
desirable. The EU baseline survey carried out in 2008 identified a trend in countries with higher 
prevalence of Campylobacter positive poultry flocks to produce poultry carcasses with high numbers 
of Campylobacter due to Campylobacter in the intestines of infected chickens contaminating the food 
processing environment and the poultry products [46]. In fact, high numbers of Campylobacter in the 
cecum of chickens for slaughter can correlate with high numbers of Campylobacter on chicken 
carcasses [47]. Campylobacter control strategies that can significantly reduce the probability of 
Campylobacter introduction into a flock and/or the numbers of Campylobacter in already infected 
chickens should be implemented from a public health perspective. On the other hand, poultry 
producers will usually make strategic decisions based on financial gains and therefore a reward system 
that can translate to an attractive cost-reward balance will be a good incentive for poultry producers to 
implement Campylobacter control strategies. In actual fact, the financial results obtained from the 
model when using the reward system 1 and a hypothetical Campylobacter vaccine B indicated that the 
expected financial gains might be too small to justify the use of vaccine B in this case. Nevertheless, 
this type of information might prove very valuable and it is likely that producers will find this 
decision-making tool more beneficial at times when the consequences from implementing alternative 
decisions for the control of Campylobacter are not very clear. In contrast, when considering the reward 
system 2 and the use of vaccine C, significant reductions in expected Campylobacter levels and 
substantial expected financial gains were obtained. Sensitivity analyses can be used to test diverse 
hypothetical vaccines and reward systems in order to compare them and their combinations. 
The aim of the sensitivity analyses was to determine the sensitivity of the vaccination decision 
under different evidence scenarios with respect to single parameters of the models but we did not 
perform sensitivity analyses on the probabilistic quantification of the model. The cost-reward functions 
are crucial drivers for the selection of the optimal decision which is determined based on the principle 
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of maximum benefit (cost-reward balance). It is important to bear in mind that in the model the cost 
function relates only to the cost of the control measure and does not include any other additional costs 
such as those related to microbiological testing. 
Financial data considered in the models should be as accurate as possible (e.g., cost of a specific 
Campylobacter control). The reward system might not be in place in most parts of the world, therefore 
it should be hypothesized and tailor-made based on the gross profit/per chicken for farmers in specific 
areas and/or production systems (e.g., organic farmers might obtain a higher gross profit/chicken than 
farmers producing commercial broilers). The reward system currently used in Denmark is based on an 
extra payment of about 2% for flocks testing negative for Campylobacter while in Norway and 
Sweden the payment is reduced by about 4% for flocks that test positive for Campylobacter (personal 
communication). The results from the model presented here indicate that it might be useful for the 
reward system to be based on an increased extra payment for flocks testing negative for 
Campylobacter in order to justify financially the use of a commercial vaccine against Campylobacter. 
However, financial gain will depend on the effectiveness of the vaccine (and/or other control 
strategies) and the costs associated with the controls. A cost-efficient vaccine against Campylobacter 
in chickens is not commercially available at present. We considered that the market price of a  
cost-effective vaccine against Campylobacter in chickens should be less than 10% of the gross profit 
per chicken to be competitive. Nonetheless, the market price could be higher depending on the 
effectiveness of the vaccine and the reward system. 
There are many potential strategies for the control of Campylobacter in poultry that could be 
included in the models but the complexity of the models will increase significantly. Campylobacter 
vaccination strategies have been considered in the models presented in this paper but the authors are 
working on different models where three Campylobacter control strategies (and their combinations) 
are included. Consequently, the selection of Campylobacter control strategies in poultry will become 
more and more complex due to the increased number of possibilities, and poultry producers may 
benefit from the use of decision support models. The flexibility of PGMs allows for the inclusion of 
more than one hypothetical Campylobacter vaccine and other control measures and more than one 
reward system. The users might then obtain a range of potential solutions for the control of 
Campylobacter in poultry. The most profitable solutions will be more attractive for poultry farmers, 
although they might not be feasible in the real world. On the other hand, some producers may be 
inclined to implement food safety controls (even when there is little financial reward involved)  
if the controls improve the image of their brands and/or the producers feel pressure from consumers 
and/or governments. 
From a public health perspective, results from the model in terms of expected reductions in the 
numbers of Campylobacter in chickens after the implementation of controls could be translated into 
the expected decrease in human Campylobacteriosis cases and expected reductions in associated health 
care costs using mathematical models. However, at present, a risk assessment model to estimate the 
number of human cases based on the occurrence of Campylobacter in chickens sent for slaughter does 
not seem to be available. Information related to public health benefits that could be obtained from the 
implementation of cost-effective Campylobacter controls in poultry will prove very useful, for 
example, when considering future reward systems. 
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PGMs represent knowledge and probabilistic conditional relationships in structured models 
designed to represent real situations where uncertainty plays an important role. The integration of 
information, knowledge and technology is crucial to discover new/better solutions to complex 
problems [48,49] and may aid poultry farmers to make optimal decisions on the implementation of 
controls against Campylobacter. In addition, engagement of different stakeholders in the PGMs’ 
development process is highly desirable. The use of sophisticated and complex computing interfaces, 
mathematical expressions and probability distributions needs to be reconciled with a simple and 
efficient tool that can be used by different stakeholders [50,51]. Considerations regarding the 
epidemiological and microbiological factors to be included in the models together with important 
challenges for the development of the quantitative part of the models have been presented in  
this manuscript. 
5. Conclusions 
Poultry producers should implement cost-effective Campylobacter control strategies in order to 
protect public health and to reduce the burden of human Campylobacteriosis. Decision support tools 
such as probabilistic graphical models (PGMs) will aid poultry producers to select cost-effective 
Campylobacter control strategies. The cost-reward functions and the effectiveness of the control 
strategies integrated in the models are crucial drivers for the selection of optimal decision/s. The public 
health impact of the control strategies depends on the effectiveness of the controls. The model’s 
optimal decision in every case is determined based on the principle of maximum benefit (cost-reward 
balance). Poultry producers will be able to choose from a range of potential solutions for the control of 
Campylobacter in poultry. Some decisions might be ideal from a public health perspective but may be 
costly for producers. The flexibility of PGMs allows for the consideration of diverse real-life 
circumstances, the integration of new knowledge, the inclusion of more than one Campylobacter 
control measures and more than one reward system. Nonetheless, the selection of epidemiological 
evidence, qualitative and quantitative data needs to be clearly specified to add value and perspective to 
the decision support system designed in every case. 
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